methylene blue has been researched along with Depression in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Aderibigbe, AO; Ajayi, AM; Ben-Azu, B; Iwalewa, EO; Umukoro, S | 1 |
| Sohn, JT | 1 |
| Koizumi, K; Nabeta, R; Nakamura, Y; Oka, JI; Sasaki-Hamada, S | 1 |
| Eiferman, DS; Fenn, AM; Godbout, JP; Lifshitz, J; Moussa, DN; Muccigrosso, MM; Popovich, PG; Skendelas, JP | 1 |
| Delport, A; Harvey, BH; Petzer, A; Petzer, JP | 1 |
| Alda, M; Blagdon, R; Dursun, S; Garnham, J; Hajek, T; MacLellan, S; MacQueen, G; McKinnon, M; Nair, C; O'Donovan, C | 1 |
| Dhir, A; Kulkarni, SK | 1 |
| RYSANEK, K; VITEK, V; VOJTECHOVSKY, M | 1 |
| Cerchierini, E; Crivellari, M; Landoni, G; Marino, G; Pappalardo, F; Sparicio, D; Zangrillo, A | 1 |
| Barthel, H; Burchert, W; Dannenberg, C; Kämpfer, I; Kluge, R; Knapp, WH; Seese, A | 1 |
| Gyr, K; Haensch, G; Kocher, R; Meran, A; Pfaltz, CR | 1 |
1 trial(s) available for methylene blue and Depression
| Article | Year |
|---|---|
Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study.
Topics: Adult; Anxiety; Bipolar Disorder; Cognitive Dysfunction; Cross-Over Studies; Depression; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Humans; Lamotrigine; Male; Methylene Blue; Middle Aged; Neuroprotective Agents; Outcome Assessment, Health Care; Triazines; Young Adult | 2017 |
10 other study(ies) available for methylene blue and Depression
| Article | Year |
|---|---|
Involvement of l-arginine-nitric oxide pathway in the antidepressant and memory promoting effects of morin in mice.
Topics: Animals; Antidepressive Agents; Arginine; Behavior, Animal; Depression; Disease Models, Animal; Flavonoids; Injections, Intraperitoneal; Male; Memory; Memory and Learning Tests; Methylene Blue; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Signal Transduction; Swimming | 2019 |
Effect of methylene blue treatment on amlodipine toxicity-induced myocardial depression.
Topics: Amlodipine; Calcium Channel Blockers; Cardiomyopathies; Depression; Humans; Methylene Blue | 2022 |
Pharmacological evidence for the relationship between the NMDA receptor and nitric oxide pathway and the antidepressant-like effects of glucagon-like peptide-2 in the mouse forced-swim test.
Topics: Animals; Antidepressive Agents; Arginine; Cyclic GMP; Depression; Dizocilpine Maleate; Glucagon-Like Peptide 2; Indazoles; Male; Methylene Blue; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phosphodiesterase 5 Inhibitors; Receptors, N-Methyl-D-Aspartate; Serine; Signal Transduction; Sildenafil Citrate; Swimming | 2019 |
Methylene blue attenuates traumatic brain injury-associated neuroinflammation and acute depressive-like behavior in mice.
Topics: Animals; Behavior, Animal; Brain Edema; Brain Injuries; Depression; Disease Models, Animal; Inflammation; Interleukin-10; Interleukin-1beta; Methylene Blue; Mice; Microglia; Tumor Necrosis Factor-alpha | 2015 |
Azure B and a synthetic structural analogue of methylene blue, ethylthioninium chloride, present with antidepressant-like properties.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Azure Stains; Cell Survival; Cells, Cultured; Depression; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Locomotion; Male; Methylene Blue; Molecular Structure; Monoamine Oxidase Inhibitors; Motivation; Rats; Rats, Sprague-Dawley | 2014 |
Antidepressant-like effect of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a putative trace amine receptor ligand involves l-arginine-nitric oxide-cyclic guanosine monophosphate pathway.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Arginine; Biogenic Amines; Brain Chemistry; Cyclic GMP; Cyclohexanols; Depression; Guanylate Cyclase; Indazoles; Isoquinolines; Male; Methylene Blue; Mice; Motor Activity; Neurotransmitter Agents; Nitric Oxide; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Piperazines; Purines; Signal Transduction; Sildenafil Citrate; Sulfones; Swimming | 2011 |
INTERPRETATION OF THE PSYCHOSTIMULATING EFFECT OF METHYLENE BLUE.
Topics: Angina Pectoris; Brain; Depression; Depressive Disorder; Indoleacetic Acids; Iproniazid; Liver; Methylene Blue; Monoamine Oxidase Inhibitors; Pharmacology; Rats; Research; Tranylcypromine | 1964 |
Methylene blue for lithium-induced refractory hypotension in off-pump coronary artery bypass graft: report of two cases.
Topics: Aged; Anastomosis, Surgical; Antidepressive Agents; Blood Pressure; Coronary Artery Bypass; Coronary Artery Disease; Depression; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hypotension; Lithium Carbonate; Male; Methylene Blue; Middle Aged; Vasodilation | 2004 |
Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride. Comparison with Tc-99m-ECD.
Topics: Adult; Aged; Aged, 80 and over; Brain; Cerebrovascular Disorders; Cobalt; Cysteine; Depression; Drug Stability; Female; Humans; Male; Methylene Blue; Middle Aged; Neurodegenerative Diseases; Organotechnetium Compounds; Radiopharmaceuticals; Scalp; Sensitivity and Specificity; Sleep Apnea Syndromes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1999 |
[Unilateral vestibular paralysis of toxoplasmosis (author's transl)].
Topics: Adult; Audiometry; Cerebrospinal Fluid Proteins; Depression; Humans; Male; Methylene Blue; Movement Disorders; Neuritis; Nystagmus, Pathologic; Paralysis; Parkinson Disease, Secondary; Peripheral Nervous System Diseases; Personality Disorders; Serologic Tests; Toxoplasmosis; Vertigo; Vestibular Function Tests; Vestibular Nerve | 1974 |